HealthEquity Quarterly Income Statement

NASDAQ: HQYConsumer DiscretionaryBusiness ServicesUSD

92.61-0.44 (-0.47%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

HealthEquity revenue and earnings

In the quarter ended Jul 31, 2026, HealthEquity generated $350.7 million in revenue, up 7.6% from the same quarter a year earlier. Net income was $65.6 million (+9.7% year over year), for a net margin of 18.7% versus a median of 16.3% in the prior 5 quarters. Gross margin was 73.5% (up from 71.4%) and operating margin 28.1%.

Diluted earnings per share came in at $0.78, up from $0.68.

Summary generated from market data by MetaCap's automated system. Methodology

HealthEquity income statement (quarterly)

HealthEquity quarterly income statement
Quarter (USD)	Q2 20272026-07-31	Q1 20272026-04-30	Q4 20262026-01-31	Q3 20262025-10-31	Q2 20262025-07-31	Q1 20262025-04-30	Q4 20252025-01-31	Q3 20252024-10-31	Q2 20252024-07-31	Q1 20252024-04-30	Q4 20242024-01-31	Q3 20242023-10-31
Revenue	350.73M	354.64M	334.59M	322.16M	325.83M	330.84M	311.82M	300.43M	299.93M	287.60M	262.39M	249.22M
Revenue growth (YoY)	+7.64%	+7.19%	+7.30%	+7.23%	+8.64%	+15.04%	+18.84%	+20.55%	+23.15%	+17.66%	+12.21%	+15.33%
Cost of Revenue	92.78M	98.33M	106.44M	94.10M	93.24M	106.53M	122.77M	103.41M	95.88M	100.46M	99.07M	90.04M
Gross Profit	257.95M	256.31M	228.15M	228.06M	232.59M	224.31M	189.04M	197.03M	204.05M	187.14M	163.32M	159.18M
Operating Expenses	159.26M	153.36M	157.08M	149.37M	142.98M	141.23M	146.89M	177.40M	145.12M	145.51M	124.43M	128.29M
Research & Development	73.92M	67.77M	70.35M	65.92M	64.80M	61.44M	64.65M	60.19M	58.58M	56.09M	55.24M	55.61M
Selling, General & Admin	58.08M	57.96M	58.45M	55.29M	49.91M	51.52M	53.06M	54.42M	53.78M	61.73M	43.70M	46.81M
Operating Income	98.69M	102.95M	71.07M	78.69M	89.61M	83.08M	42.15M	19.63M	58.93M	41.63M	38.89M	30.89M
Interest Expense	12.61M	12.59M	13.27M	14.05M	14.96M	14.86M	15.26M	18.16M	15.43M	11.79M	13.64M	13.54M
Other Income (Expense)	-10.82M	-10.54M	-10.17M	-11.16M	-11.56M	-12.13M	-12.19M	-13.41M	-12.31M	-8.39M	-9.17M	-9.80M
Pretax Income	87.86M	92.41M	60.90M	67.53M	78.05M	70.95M	29.96M	6.22M	46.62M	33.24M	29.72M	21.09M
Income Tax	22.22M	23.00M	11.16M	15.84M	18.19M	17.04M	3.60M	515.00K	10.79M	4.43M	3.35M	6.41M
Net Income	65.64M	69.42M	49.74M	51.69M	59.85M	53.91M	26.36M	5.70M	35.82M	28.81M	26.36M	14.67M
Net Income growth (YoY)	+9.67%	+28.75%	+88.66%	+806.40%	+67.09%	+87.12%	+0.00%	-61.13%	+238.55%	+603.79%	—	—
EPS (Basic)	0.79	0.82	0.59	0.60	0.69	0.62	0.30	0.07	0.41	0.33	0.31	0.17
EPS (Diluted)	0.78	0.82	0.58	0.59	0.68	0.61	0.30	0.06	0.40	0.33	0.30	0.17
Shares Outstanding (Basic)	83.37M	84.41M	—	86.00M	86.55M	86.66M	—	87.19M	87.13M	86.47M	—	85.70M
Shares Outstanding (Diluted)	84.01M	85.01M	—	86.97M	87.75M	88.42M	—	88.63M	88.65M	88.32M	—	87.12M
EBITDA	140.65M	141.17M	109.75M	117.47M	128.07M	121.82M	81.33M	60.35M	102.54M	80.57M	76.80M	68.67M
Gross Margin	73.55%	72.27%	68.19%	70.79%	71.38%	67.80%	60.63%	65.58%	68.03%	65.07%	62.24%	63.87%
Operating Margin	28.14%	29.03%	21.24%	24.43%	27.50%	25.11%	13.52%	6.53%	19.65%	14.48%	14.82%	12.40%
Net Margin	18.72%	19.57%	14.87%	16.05%	18.37%	16.30%	8.46%	1.90%	11.94%	10.02%	10.05%	5.89%

This table shows 12 quarterly periods of HealthEquity's income statement, from Q2 2027 back to Q3 2024, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow HQY's reporting calendar. What is a income statement?